(Q35564263)

8 August 2017

1 reference

title

Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutations (English)

1 reference

genetic predisposition to disease

8 August 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14569208

23 March 2024

DNA mutational analysis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14569208

23 March 2024

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

23 March 2024

author name string

S. Sohail Ahmed

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14569208

23 March 2024

Filemon K. Tan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14569208

23 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14569208

23 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://journals.lww.com/00002281-200311000-00014

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Current Opinion in Rheumatology

23 March 2024

published in

1 reference

8 August 2017

volume

15

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

766-771

1 reference

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

8 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/35000501

Initial sequencing and analysis of the human genome

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/35057062

Epidemiology of systemic sclerosis and related diseases.

1

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

The complex genetics of scleroderma

23 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

TGFβ—a role in systemic sclerosis?

23 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Smads: transcriptional activators of TGF-beta responses

23 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.

23 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Effect of halofuginone on the development of tight skin (TSK) syndrome

23 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.

23 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis.

23 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

The polymorphism of transforming growth factor-beta1 gene in Japanese patients with systemic sclerosis

23 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

23 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population

23 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Identification of an IL1A gene segment that determines aberrant constitutive expression of interleukin-1 alpha in systemic sclerosis

23 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1

23 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Gene silencing in mammals by small interfering RNAs

23 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma

23 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis

23 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Regulation of interleukin-4 on collagen gene expression by systemic sclerosis fibroblasts in culture

23 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts

23 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis

23 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

The Journal of Rheumatology

23 March 2024

20

24

328

Hasegawa

1997

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Interleukin-1, Interleukin-2, Interleukin-4, Interleukin-6, Tumor Necrosis Factor α, and Interferon-γ Levels in Sera from Patients With Scleroderma

23 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.

23 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Promoter polymorphism in the candidate genes, IL-4, IL-9, TGF-beta1, for atopy and asthma

23 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population

23 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations

23 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Association of 5'-untranslated region of the Fibrillin-1 gene with Japanese scleroderma

23 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Thrombospondin: a component of microfibrils in various tissues

23 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma)

23 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation

23 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome

23 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles

23 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene

23 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma

23 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

The Journal of Rheumatology

23 March 2024

35

19

1566

Yamane

1992

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Cutaneous localization of endothelin-1 in patients with systemic sclerosis: immunoelectron microscopic study

23 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.

23 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts

23 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Endothelin-1 regulation of intercellular adhesion molecule-1 expression in normal and sclerodermal fibroblasts

23 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin

23 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

The role of nitric oxide in inflammation and immunity

23 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis

23 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

The Journal of Rheumatology

23 March 2024

43

29

2379

Morse

2002

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases

23 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts

23 March 2024

45

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence

23 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

23 March 2024

47

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts

23 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Gene expression in bronchoalveolar lavage cells from scleroderma patients

23 March 2024

50

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21.

23 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

The structure of haplotype blocks in the human genome

23 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

High-resolution haplotype structure in the human genome

23 March 2024

54

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

Options available--from start to finish--for obtaining data from DNA microarrays II.

23 March 2024

55

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00014

23 March 2024

Identifiers

1 reference

8 August 2017

1 reference